The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Atypical Candida spp. infections are rising, mostly due to the increasing numbers of
immunocompromised patients. The most common Candida spp. is still Candida albicans; …

EFSA is requested to assess the safety of a broad range of biological agents in the context of
notification for market authorisation as sources of food and feed additives, food enzymes …

Purpose To assess the risk factors and outcomes associated with fungemia caused by the
six most commonly occurring Candida species in patients with and without malignancies …

Yeasts are eukaryotic microorganisms which have a long history in the biotechnology of
food production, as they have been used since centuries in bread-making or in the …

Many uncommon Candida species that cause bloodstream infections (BSIs) are not well-
characterized. We investigated the epidemiology, antifungal use, susceptibility patterns, and …

In this review, we describe the epidemiology and clinical significance of resistance in
Candida spp. and other non-Cryptococcus yeasts. The rise in echinocandin resistance …

Objectives The epidemiology and clinical course of candidaemia in patients with acute
leukaemia, a population frequently exposed to antifungals, have not been extensively …

Background Candidemia is a pervasive problem associated with significant morbidity and
mortality in health care settings. This study aimed to determine the changing distribution of …

Increased incidences of Candida infection have augmented morbidity and mortality in
human population, particularly among severely immunocompromised patients and those …